We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Hematogenix®, a global leader in integrated pathology services for drug development and immuno-oncological testing, today announced the introduction of the companion diagnostic test for TECENTRIQ®.